2022
DOI: 10.1021/acschemneuro.2c00357
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s Disease

Abstract: Alzheimer's disease (AD), the most common type of dementia, currently represents an extremely challenging and unmet medical need worldwide. Amyloid-β (Aβ) and Tau proteins are prototypical AD hallmarks, as well as validated drug targets. Accumulating evidence now suggests that they synergistically contribute to disease pathogenesis. This could not only help explain negative results from anti-Aβ clinical trials but also indicate that therapies solely directed at one of them may have to be reconsidered. Based on… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 65 publications
0
1
0
Order By: Relevance
“…The comprehensive studies on TZDs are presented on numerous confirmed derivatives and patents . The anti-Alzheimer’s potential of TZDs has been investigated in several studies. …”
Section: Introductionmentioning
confidence: 99%
“…The comprehensive studies on TZDs are presented on numerous confirmed derivatives and patents . The anti-Alzheimer’s potential of TZDs has been investigated in several studies. …”
Section: Introductionmentioning
confidence: 99%